PCI Biotech Holding ASA: PCI Biotech: Update on regulatory interactions for the RELEASE trial

Oslo (Norway), 7 December 2021 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company has concluded on the interactions with regulatory authorities in the

Related Keywords

Norway ,Norwegian , ,Europe European Medicines Agency ,Drug Administration ,European Medicines Agency ,Norwegian Securities Trading ,Biotech ,Molding ,Update ,Egulatory ,Interactions ,Release ,Trial ,